Best Topics

Adar Poonawalla: Latest News

All news where Adar Poonawalla is mentioned

Adar Poonawalla - This country is first to approve Covid vaccine that targets both original and Omicron strain - livemint.com - India - Britain - Australia - Canada - Eu

16.08.2022 / 04:07

This country is first to approve Covid vaccine that targets both original and Omicron strain

FURTHER APPROVALS European Medicines Agency (EMA) officials expect COVID variant-adapted vaccines to be approved in the European Union by September, and have signalled the regulator is open to using shots targeting the older BA.1 variant this autumn, given those specifically targeting newer subvariants are further behind in clinical development. In contrast, the U.S.

Adar Poonawalla India Britain Australia Canada Eu vaccine strain Target

Adar Poonawalla - Omicron-specific Covid vaccine for India in 6 months, expects Adar Poonawalla - livemint.com - Usa - India - Britain

15.08.2022 / 17:39

Omicron-specific Covid vaccine for India in 6 months, expects Adar Poonawalla

Serum Institue of India's Adar Poonawalla said he expects an Omicron-specific Covid-19 vaccine for India in 6 months Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said on Monday that he expects an Omicron-specific vaccine against the coronavirus for India in six months Adar Poonawalla, the world's biggest vaccine maker, produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. "Think this vaccine is important as a booster," Adar Poonawalla was quoted as saying. Meanwhile, the United Kingdom has given the first green light to a variant-adapted shot that targets both the original and Omicron version of the coronavirus.

Adar Poonawalla Usa India Britain covid-19 vaccine Coronavirus

Adar Poonawalla - Mansukh Mandaviya - Yet another Covid vaccine…: What SII's Adar Poonawalla said after NTAGI clears Covovax for 12-17 age grp - livemint.com - India

03.05.2022 / 17:35

Yet another Covid vaccine…: What SII's Adar Poonawalla said after NTAGI clears Covovax for 12-17 age grp

@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90%. This is in line with Shri @narendramodi Ji's vision of providing yet another vaccine to protect our children. pic.twitter.com/QUm7sZyOfi

Adar Poonawalla Mansukh Mandaviya India covid-19 recommendations vaccine

Adar Poonawalla - Rajeev Jayadevan - COVID booster dose: Can Covishield, Covaxin provide better protection against Omicron, new variants? - livemint.com - India

09.04.2022 / 15:27

COVID booster dose: Can Covishield, Covaxin provide better protection against Omicron, new variants?

Covaxin robustly triggered neutralising antibody responses and efficiently neutralised the multiple variants of SARS-CoV-2, Sakpal said.

Adar Poonawalla Rajeev Jayadevan India vaccine Waves Provident

Roland Garros - Adar Poonawalla - ‘Hope you change your mind’: Adar Poonawalla on Djokovic's Covid vaccine stance - livemint.com - India - France

17.02.2022 / 19:33

‘Hope you change your mind’: Adar Poonawalla on Djokovic's Covid vaccine stance

Novak Djokovic stated he would skip the French Open and Wimbledon rather than get vaccinated against Covid-19, Serum Institute of India (SII) chief Adar Poonawalla took to Twitter to say that he hopes the tennis star changes his mind.

Roland Garros Adar Poonawalla India France information vaccine Government

Adar Poonawalla - India stuck with Covid-19 vaccines it can't export - livemint.com - city New Delhi - India

14.12.2021 / 15:18

India stuck with Covid-19 vaccines it can't export

Adar Poonawalla city New Delhi India covid-19 vaccine Government

Adar Poonawalla - Serum CEO Adar Poonawalla says covid vaccine for children in six months - livemint.com - India

14.12.2021 / 10:41

Serum CEO Adar Poonawalla says covid vaccine for children in six months

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Adar Poonawalla India information vaccine CEO

Boris Johnson - Adar Poonawalla - Britain's covid entry norms are ‘total chaos’: SII CEO Adar Poonawalla - livemint.com - India - Britain

01.10.2021 / 11:41

Britain's covid entry norms are ‘total chaos’: SII CEO Adar Poonawalla

The Telegraph in an exclusive interview.

Boris Johnson Adar Poonawalla India Britain vaccine quarantine Health

Adar Poonawalla - SII says Covishield cheaper than most covid-19 medical treatment - livemint.com - India

24.04.2021 / 15:01

SII says Covishield cheaper than most covid-19 medical treatment

Serum Institute of India chief executive officer Adar Poonawalla on Saturday said the vaccine was cheaper than most covid-19 treatments, and increasing its price was necessary to keep its production sustainable.The company will charge ₹400 per dose for Covishield from the Centre and states for fresh orders and ₹600 per dose from private hospitals from 1 May.“Only a limited portion of SII's volume will be sold to private hospitals at INR 600 per dose.

Adar Poonawalla India covid-19 vaccine Government

Justin Trudeau - Narendra Modi - Adar Poonawalla - India to ship COVID-19 vaccines to Canada as diplomatic tension eases - livemint.com - India - Canada - city Delhi

15.02.2021 / 16:58

India to ship COVID-19 vaccines to Canada as diplomatic tension eases

BENGALURU : India's Serum Institute will ship COVID-19 vaccines to Canada within a month, its chief executive said on Monday, in a sign a diplomatic row triggered by Canadian Prime Minister Justin Trudeau's comments on political protests in India was easing.Trudeau said the months-long protests by farmers on the outskirts of Delhi were concerning, drawing a rebuke from the Indian government which said it was an internal matter.Last week, however, Trudeau spoke to Indian counterpart Narendra Modi and they discussed the two countries' commitment to democracy.Modi also said India would do its best to supply COVID-19 vaccines sought by Canada.On Monday Adar Poonawalla, the chief executive of Serum Institute of India (SII) - the world's largest

Justin Trudeau Narendra Modi Adar Poonawalla India Canada city Delhi covid-19 vaccine Government

Adar Poonawalla - Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine - livemint.com - Britain

29.01.2021 / 08:48

Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine

Novavax coronavirus vaccine that was found to be 89.3% effective in a UK trial, its Chief Executive Officer Adar Poonawalla told news agency Reuters on Friday.Earlier today, Novavax said that its Covid-19 vaccine was 89.3% effective in preventing the killer virus in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in Britain, as per a preliminary analysis.Also Read | Covid vaccination faces slow startNovavax is reportedly stockpiling Covid-19 vaccines at six operating manufacturing sites and said it expects a total of eight plants in seven countries to produce at the rate of 2 billion doses per year, including from the SII, a major player in the

Adar Poonawalla Britain covid-19 vaccine Coronavirus

Adar Poonawalla - Saudi Arabia to get covid vaccines in about a week from India - livemint.com - Usa - India - Saudi Arabia

26.01.2021 / 06:29

Saudi Arabia to get covid vaccines in about a week from India

The Indian-Americans driving Biden’s agendaSII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make up to a billion doses for poorer countries.The Indian company supplies doses on behalf of AstraZeneca but is also free to strike its own supply deals."We continue to support AstraZeneca wherever they need the support. We are happy to do so," Chief Executive Adar Poonawalla told Reuters in an interview."But we have not been asked to supply any more products for Europe because then that would mean supplies to Africa and India would suffer, and we certainly don't want that," he said.

Adar Poonawalla Usa India Saudi Arabia covid-19 vaccine Government

Adar Poonawalla - Serum Institute chief Adar Poonawalla takes covid vaccine - livemint.com

16.01.2021 / 11:15

Serum Institute chief Adar Poonawalla takes covid vaccine

@narendramodi ji great success in launching the world’s largest COVID vaccination roll-out. It brings me great pride that #COVISHIELD is part of this historic effort & to endorse it’s safety & efficacy, I join our health workers in taking the vaccine myself.

Adar Poonawalla vaccine Government

Adar Poonawalla - Brazil sends plane after Indian govt agrees to expedite Covid-19 vaccine supply - livemint.com - Usa - India - Brazil

14.01.2021 / 16:54

Brazil sends plane after Indian govt agrees to expedite Covid-19 vaccine supply

Narendra Modi agreed to expedite vaccine shipment to the South American country.The Serum Institute of India Pvt., the world’s largest producer of vaccines by volume, will supply 2 million doses of the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford to Brazil, according to the nation’s Health Minister Eduardo Pazuello.Serum’s Chief Executive Officer Adar Poonawalla in an interview this month said he expected overseas supplies to only start around March, adding that the government will enable overseas sales after first meeting India’s initial requirements.A spokesman for Serum didn’t respond to a text message seeking comment on the sale to Brazil, while an Indian foreign ministry spokesman declined to comment.

Adar Poonawalla Usa India Brazil vaccine Government

Adar Poonawalla - Who's on the hook if Covid vaccines go wrong? - livemint.com - India

07.01.2021 / 03:13

Who's on the hook if Covid vaccines go wrong?

Covid-19 vaccines are here and distribution has begun. But what if something goes wrong?Whether it’s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, be it vaccine manufacturers or governments.

Adar Poonawalla India pandemic vaccine Government

Adar Poonawalla - Delays over pricing holds back India’s vital Covid-19 vaccine rollout - livemint.com - India

06.01.2021 / 03:21

Delays over pricing holds back India’s vital Covid-19 vaccine rollout

Serum Institute of India Ltd. -- the world’s biggest vaccine maker by volume and AstraZeneca Plc’s local partner -- have engaged in months of haggling behind closed doors and are yet to sign a formal supply agreement.

Adar Poonawalla India vaccine Government

Adar Poonawalla - India says it hasn't banned the export of COVID-19 vaccines - clickorlando.com - city New Delhi - India

clickorlando.com

05.01.2021 / 20:11

India says it hasn't banned the export of COVID-19 vaccines

NEW DELHI – India's government had not banned the export of any vaccines for COVID-19, the health ministry said Tuesday, days after the head of the world’s largest vaccine manufacturer said it got emergency authorization to produce the shots as long as it didn't send them overseas.Adar Poonawalla, chief executive of Serum Institute of India, told The Associated Press in an interview Sunday that the company got the green light for its version of the AstraZeneca/Oxford University vaccine on the condition that it not export shots to ensure that vulnerable populations in India are protected. AstraZeneca contracted Serum Institute of India to manufacture 1 billion doses for developing nations.

Adar Poonawalla city New Delhi India covid-19 vaccine

Adar Poonawalla - Serum Institute expects India nod for Covid-19 vaccine emergency use in next few days: Report - livemint.com - India - Britain

28.12.2020 / 15:05

Serum Institute expects India nod for Covid-19 vaccine emergency use in next few days: Report

Serum Institute of India, which is also manufacturing the Oxford-AstraZeneca coronavirus vaccine in India, said on Monday it expected the government to approve the shot for emergency use in a few days, reported Reuters.Serum Chief Executive Adar Poonawalla also told reporters that the company had already made 40 million to 50 million doses of the vaccine.According to a Mint report, India is likely to approve Oxford-AstraZeneca's coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities.This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials.Currently,

Adar Poonawalla India Britain vaccine Coronavirus

Adar Poonawalla - Govt must indemnify vaccine makers against all lawsuits: Serum Institute chief Adar Poonawalla - livemint.com - city New Delhi - India

20.12.2020 / 13:48

Govt must indemnify vaccine makers against all lawsuits: Serum Institute chief Adar Poonawalla

NEW DELHI : Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said.He also said that the vaccine makers are going to propose this to the government, while speaking at a virtual panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit on Friday."We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits.

Adar Poonawalla city New Delhi India pandemic vaccine Government

Adar Poonawalla - Serum CEO wants Covid-19 vaccine makers to be indemnified from legal liability - livemint.com - city New Delhi - India

18.12.2020 / 19:33

Serum CEO wants Covid-19 vaccine makers to be indemnified from legal liability

₹5 crore legal notice against the company New Delhi: Serum Institute of India chief executive officer Adar Poonawalla wants makers of Covid-19 vaccine in to be indemnified from legal liability in case there are any serious adverse events or any other issues.“This is especially important only during a pandemic to indemnify vaccine manufacturers against lawsuits for severe adverse effects or any other frivolous claims which may come about, because that adds to the fear (about vaccines)," Poonawalla said at the Carnegie India’s Global Technology Summit on Friday.Poonawalla said that the government should come with a law to as it would help companies focus on developing and manufacturing the vaccines and not address legal issues and explain to

Adar Poonawalla city New Delhi India covid-19 vaccine economy

Adar Poonawalla - Covid-19 vaccine: SII's Poonawalla thanks PM Modi for his invaluable support - livemint.com - India - Britain - city Oxford

07.12.2020 / 09:07

Covid-19 vaccine: SII's Poonawalla thanks PM Modi for his invaluable support

Serum Institute of India (SII) has sought government approval for emergency use authorisation of the Covid-19 vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca. SII's Chief Executive Officer Adar Poonawalla today took to Twitter to thank Government of India and PM Narendra Modi for their invaluable support."As promised, before the end of 2020, Serum Institute of India has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD.

Adar Poonawalla India Britain city Oxford covid-19 2020 pandemic vaccine Government

Adar Poonawalla - Rajesh Bhushan - Government says serious adverse event will not delay launch of first covid-19 vaccine - livemint.com - India - Britain

01.12.2020 / 17:26

Government says serious adverse event will not delay launch of first covid-19 vaccine

Serum Institute of India’s Covishield trial.“The adverse event will not affect the timelines in any manner whatsoever," health secretary Rajesh Bhushan said on Tuesday.Serum Institute’s Covishield is widely expected to be available for immunisation of front health workers starting as early as January.On Saturday, the chief executive officer of the world’s largest vaccine manufacturer, Adar Poonawalla, said that the company plans to apply to the Drug Controller General of India for an emergency use license for the vaccine in about two weeks using the data from AstraZeneca’s phase 3 trial in the UK as well as the company’s own phase 2 and 3 bridging study in India.Covishield is originally developed by AstraZeneca and the University of

Adar Poonawalla Rajesh Bhushan India Britain covid-19 vaccine Government

Adar Poonawalla - Oxford covid vaccine: Serum Institute expects emergency authorization next month - livemint.com - city New Delhi - India - city Pune

13.11.2020 / 10:01

Oxford covid vaccine: Serum Institute expects emergency authorization next month

Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month.If final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- which is partnered to produce at least one billion doses -- may get emergency authorization from New Delhi by December, said Adar Poonawalla, chief executive officer of the family-owned firm based in the Pune.That initial amount will go to India, Poonawalla said in an interview on Thursday.

Adar Poonawalla city New Delhi India city Pune covid-19 vaccine infection

Adar Poonawalla - Serum Institute readies 4 crore doses of covid vaccine, expecting January launch - livemint.com - India - Britain

12.11.2020 / 08:55

Serum Institute readies 4 crore doses of covid vaccine, expecting January launch

interview with Mint, Serum Institute CEO Adar Poonawalla said that a vaccine against the coronavirus disease is likely to be available in the country by January 2021 provided approvals from regulatory bodies are in place in time.“Based on the success of the trials in India and the United Kingdom, and if approvals from regulatory bodies are in place in time, then we can expect the vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious." Poonawalla had said.Meanwhile, SII and ICMR announced the completion of enrolment of phase-3 clinical trials for the novel coronavirus vaccine-Covishield-in India.

Adar Poonawalla India Britain covid-19 testing vaccine Coronavirus

Adar Poonawalla - COVID-19 vaccine: Serum Institute ties-up with 5 candidates; Poonawalla says 'it will be affordable' - livemint.com - Usa - Britain

05.11.2020 / 15:56

COVID-19 vaccine: Serum Institute ties-up with 5 candidates; Poonawalla says 'it will be affordable'

Mint.Under an agreement with US drug developer, Serum Institute will develop two billion doses of Novavax's vaccine candidate annually. The drugmaker will also manufacture the antigen component of the vaccine.

Adar Poonawalla Usa Britain covid-19 vaccine Coronavirus

Adar Poonawalla - ₹80,000 cr for covid vaccine in next 1 year: Serum Institute CEO - livemint.com - city New Delhi - India - city Sanford

26.09.2020 / 15:42

₹80,000 cr for covid vaccine in next 1 year: Serum Institute CEO

₹80,000 crore, or around $11 billion, is substantially higher than the $6-bn estimate made by international brokerage Sanford Bernstein NEW DELHI: The government may need ₹80,000 crore over the next one year for distribution of covid-19 vaccine to every person in India, Serum Institute of India chief executive officer Adar Poonawalla said on Saturday, calling it a "concerning challenge"."Will the government of India have 80,000 crores available, over the next one year? Because that's what @MoHFW_INDIA (health ministry) needs, to buy and distribute the vaccine to everyone in India.

Adar Poonawalla city New Delhi India city Sanford covid-19 vaccine Government

Adar Poonawalla - Oxford COVID-19 vaccine: Serum Institute to resume trial in India after DCGI's nod - livemint.com - India - Britain - city Pune

12.09.2020 / 19:39

Oxford COVID-19 vaccine: Serum Institute to resume trial in India after DCGI's nod

Astrazeneca resumed Oxford University coronavirus vaccine trial in the United Kingdom, Serum Institute of India on Saturday said that they will restart the trial in the country once the apex drug regulator allows. Commenting on the resumption of trial, Adar Poonawalla, the chief executive officer of Serum Institute of India said, "We should not jump to conclusions until the trials are fully concluded."AstraZeneca paused its trials late Tuesday after observing “a single event of an unexplained illness that occurred in the UK phase III trial".

Adar Poonawalla India Britain city Pune covid-19 recommendations vaccine Coronavirus

Adar Poonawalla - Serum Institute of India, Novavax in covid vaccine deal, may produce 100 crore doses - livemint.com - India

07.08.2020 / 07:30

Serum Institute of India, Novavax in covid vaccine deal, may produce 100 crore doses

Novavax have announced an agreement for the development and commercialization of Novavax’ COVID‑19 vaccine candidate in India and other low- and middle-income countries. The agreement is expected to support minimum of 1 billion doses of NVX-CoV2373 for India and low- and middle-income countries, Novavax said.“We believe that Novavax’ NVX-CoV2373 has significant potential to successfully prevent COVID-19.

Adar Poonawalla India covid-19 vaccine prevention malaria

Adar Poonawalla - Oxford COVID-19 vaccine: All you need to know about price, trial, production in India - livemint.com - India - Britain - Brazil - Sweden - county Oxford - city Oxford

22.07.2020 / 14:09

Oxford COVID-19 vaccine: All you need to know about price, trial, production in India

Oxford's COVID-19 vaccine has shown a positive result in its initial trial. According to a report published in the British medical journal, The Lancet, the COVID-19 vaccine produced a dual immune response in people aged 18 to 55.Officially known as AZD1222, this COVID-19 vaccine candidate has been developed by the University of Oxford and British-Swedish pharmaceutial company AstraZeneca Plc.

Adar Poonawalla India Britain Brazil Sweden county Oxford city Oxford covid-19 vaccine patient

Adar Poonawalla - Serum Institute to begin trials of Oxford's Covid-19 vaccine by August-end - livemint.com - India - city Pune

22.07.2020 / 04:59

Serum Institute to begin trials of Oxford's Covid-19 vaccine by August-end

Oxford University and AstraZeneca by the end of August on up to 5,000 Indian volunteers after getting the necessary nods, and launch the vaccine by June next year if all goes well.The Pune-based company's chief executive Adar Poonawalla said the company, which is the largest vaccine maker in the world, is putting USD 200 million at risk by manufacturing nearly 300 million doses before the final nod to launch the vaccine in market, which is expected at best by the end of the year.Oxford University on Monday announced satisfactory progress with the vaccine, making it one of the leading ones among the dozens of vaccine candidates being developed around the world.The varsity has tied up with Serum Institute of India (SII) to manufacture and

Adar Poonawalla India city Pune covid-19 vaccine Volunteers patient

Adar Poonawalla - Oxford coronavirus vaccine trial, manufacturing in India soon - livemint.com - India - county Oxford - city Pune

21.07.2020 / 07:43

Oxford coronavirus vaccine trial, manufacturing in India soon

Serum Institute of India, the largest vaccine manufacturer in the world, is a partner in the Oxford vaccine project and has been chosen by Oxford and AstraZeneca to manufacture the vaccine once it gets ready."The trials have shown promising results and we are extremely happy about it.

Adar Poonawalla India county Oxford city Pune covid-19 vaccine Coronavirus

Adar Poonawalla - Oxford’s covid-19 vaccine shown to be safe, starts providing immunity in 14 days - livemint.com - city New Delhi - India - Britain - city Oxford

20.07.2020 / 18:41

Oxford’s covid-19 vaccine shown to be safe, starts providing immunity in 14 days

NEW DELHI : In a glimmer of hope for the world reeling under the covid-19 pandemic, interim data from a clinical study published in The Lancet, a peer-reviewed medical journal, on Monday showed that the University of Oxford’s vaccine candidate was safe and started providing immunity against the fatal respiratory disease after 14 days of the first dose.The vaccine candidate is being co-developed by the University of Oxford and British pharmaceutical giant AstraZeneca plc, with the Serum Institute of India mass producing it for low-and-middle income countries, including India.Serum Institute chief executive officer Adar Poonawalla said that the company would soon be applying for permission from the Drug Controller General of India V.G.

Adar Poonawalla city New Delhi India Britain city Oxford virus covid-19 pandemic vaccine

Adar Poonawalla - Pune's Serum Institute to start making coronavirus vaccine that is under trial - livemint.com - India - county Hill - county Oxford - city Pune

26.04.2020 / 11:57

Pune's Serum Institute to start making coronavirus vaccine that is under trial

Vaccine major Serum Institute of India today said it plans to start production of the COVID-19 vaccine developed by Oxford University in the next two to three weeks and hopes to bring it to the market by October if the human clinical trials are successful.

Adar Poonawalla India county Hill county Oxford city Pune covid-19 vaccine malaria Coronavirus

COVID-19

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Detail statistic

About Us

Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories

Info

For advertisers

Advertising Questions ?

Add Post

Add Source

©2024. All rights reserved.

DMCA